United States· US:46708-582_59488591-1d11-453f-b2f2-b2a47825819a

Lidocaine and Prilocaine

A medicinal product containing lidocaine; prilocaine, registered in United States by Alembic Pharmaceuticals Limited.

US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lidocaine; prilocaineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: LIDOCAINE; PRILOCAINE
Manufacturer: Alembic Pharmaceuticals Limited
Country: United States (US)
ATC code: —
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 4

ndc11
46708-582-04
ndc11
46708-582-31
ndc11
4670858204
1 TUBE in 1 CARTON (46708-582-04) / 5 g in 1 TUBE
ndc11
4670858231
1 TUBE in 1 CARTON (46708-582-31) / 30 g in 1 TUBE

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lidocaine; prilocaine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lidocaine; prilocaine products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Emla, Emla Pflaster
Belgium · Emla, Emla Patch
Cyprus · Emla, Xylocream
Czechia · Emla
Germany · Anesderm, Emla
Denmark · Emla, Lidocain/Prilocain Idd
Estonia · Nulbia
Spain · Anamap®, Anestderma
Finland · Emla, Oraqix
France · Anesderm, Emla
United Kingdom (Northern Ireland) · Emla, Nulbia
Greece · Emla, Nulbia
Hungary · Li-Pri
Ireland · Emla, Oraqix
Iceland · Emla, Fortacin
Italy · Emla, Lidocaina E Prilocaina Teva
Liechtenstein · Fortacin
Luxembourg · Emla, Emla Patch
Malta · Emla, Opralix
Netherlands · Emla, Lidocaïne/Prilocaïne Teva
Norway · Emla, Fortacin
Poland · Anesderm, Emla
Portugal · Emla, Emla Penso
Romania · Romla
Sweden · Emla, Oraqix
Slovakia · Romla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e4576da8-5db3-458d-bdfe-f55a5db51276
GET /v1/drugs/e4576da8-5db3-458d-bdfe-f55a5db51276?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "25; 25",
  "substance": "LIDOCAINE; PRILOCAINE",
  "productndc": "46708-582",
  "dosage_form": "CREAM",
  "dea_schedule": null,
  "strength_unit": "mg/g; mg/g",
  "application_number": "ANDA213923",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about lidocaine; prilocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console